2020 Stop-Loss Research Report

2020 Stop-Loss Research Report High-cost claims and injectable drug trends analysis

November 2020

In this report, the expanded high-cost claim conditions analysis that was published as an early release in May is combined with our new top 20 injectable drugs list and the latest data on million-dollar+ claims. A healthcare update is also included, covering what we have seen to date on COVID-19 claims, the latest information on Zolgensma and a new emerging gene therapy, and several legislative updates. Fill out the form below to get your free copy of the “High-cost claims and injectable drug trends analysis."


*All fields are required.